From data analysis to risk assessments: Linking transcriptomics to molecular Adverse Outcome Pathway frameworks

This presentation was given as part of the SCAHT AOP HUB meeting on November 7th, 2024, and covered the efforts on molecular Adverse Outcome Pathways to allow the linking and analysis of transcriptomic data, followed by a discussion on the approach.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-12-11
DOI
https://doi.org/10.5281/zenodo.14391431
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

From data analysis to risk assessments: Linking transcriptomics to molecular Adverse Outcome Pathway frameworks

Zenodo (CERN European Organization for Nuclear Research)
Tuberculosis Research and Epidemiology
article

From data analysis to risk assessments: Linking transcriptomics to molecular Adverse Outcome Pathway frameworks

article en

Abstract

This presentation was given as part of the SCAHT AOP HUB meeting on November 7th, 2024, and covered the efforts on molecular Adverse Outcome Pathways to allow the linking and analysis of transcriptomic data, followed by a discussion on the approach.

Zenodo (CERN European Organization for Nuclear Research)
Maastricht University (NL)
Openalex Percentile: Top 55%
Tuberculosis Research and Epidemiology
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

From data analysis to risk assessments: Linking transcriptomics to molecular Adverse Outcome Pathway frameworks · Zenodo (CERN European Organization for Nuclear Research) (2024) | TGRS Research Map | TGRS